tetano
Editor, Senior Moderator
J Med Virol
. 2024 Sep;96(9):e29891.
doi: 10.1002/jmv.29891. E3 ubiquitin ligase FBXO22 inhibits SARS-CoV-2 replication via promoting proteasome-dependent degradation of NSP5
Yuzheng Zhou[SUP] 1 [/SUP], Wei Feng[SUP] 1 [/SUP], Chuwei Yang[SUP] 1 [/SUP], Xiafei Wei[SUP] 1 [/SUP], Lujie Fan[SUP] 1 [/SUP], Yezi Wu[SUP] 1 [/SUP], Xiang Gao[SUP] 1 [/SUP], Xiaotong Shen[SUP] 1 [/SUP], Zheng Zhang[SUP] 1 2 [/SUP], Juanjuan Zhao[SUP] 1 [/SUP]
Affiliations
The ubiquitin-proteasome system is frequently employed to degrade viral proteins, thereby inhibiting viral replication and pathogenicity. Through an analysis of the degradation kinetics of all the SARS-CoV-2 proteins, our study revealed rapid degradation of several proteins, particularly NSP5. Additionally, we identified FBXO22, an E3 ubiquitin ligase, as the primary regulator of NSP5 ubiquitination. Moreover, we validated the interaction between FBXO22 and NSP5, demonstrating that FBXO22-mediated ubiquitination of NSP5 facilitated its recognition by the proteasome, leading to subsequent degradation. Specifically, FBXO22 catalyzed the formation of K48-linked polyubiquitin chains on NSP5 at lysine residues 5 and 90. Knockdown of FBXO22 resulted in decreased NSP5 ubiquitination levels, increased stability, and enhanced ability to evade the host innate immune response. Notably, the protein level of FBXO22 were negatively correlated with SARS-CoV-2 load, highlighting its importance in inhibiting viral replication. This study elucidates the molecular mechanism by which FBXO22 mediates the degradation of NSP5 and underscores its critical role in limiting viral replication. The identification of FBXO22 as a regulator of NSP5 stability provides new insights and potential avenues for targeting NSP5 in antiviral strategies.
Keywords: NSP5; SARS‐CoV‐2; degradation; ubiquitination; viral replication.
. 2024 Sep;96(9):e29891.
doi: 10.1002/jmv.29891. E3 ubiquitin ligase FBXO22 inhibits SARS-CoV-2 replication via promoting proteasome-dependent degradation of NSP5
Yuzheng Zhou[SUP] 1 [/SUP], Wei Feng[SUP] 1 [/SUP], Chuwei Yang[SUP] 1 [/SUP], Xiafei Wei[SUP] 1 [/SUP], Lujie Fan[SUP] 1 [/SUP], Yezi Wu[SUP] 1 [/SUP], Xiang Gao[SUP] 1 [/SUP], Xiaotong Shen[SUP] 1 [/SUP], Zheng Zhang[SUP] 1 2 [/SUP], Juanjuan Zhao[SUP] 1 [/SUP]
Affiliations
- PMID: 39223933
- DOI: 10.1002/jmv.29891
The ubiquitin-proteasome system is frequently employed to degrade viral proteins, thereby inhibiting viral replication and pathogenicity. Through an analysis of the degradation kinetics of all the SARS-CoV-2 proteins, our study revealed rapid degradation of several proteins, particularly NSP5. Additionally, we identified FBXO22, an E3 ubiquitin ligase, as the primary regulator of NSP5 ubiquitination. Moreover, we validated the interaction between FBXO22 and NSP5, demonstrating that FBXO22-mediated ubiquitination of NSP5 facilitated its recognition by the proteasome, leading to subsequent degradation. Specifically, FBXO22 catalyzed the formation of K48-linked polyubiquitin chains on NSP5 at lysine residues 5 and 90. Knockdown of FBXO22 resulted in decreased NSP5 ubiquitination levels, increased stability, and enhanced ability to evade the host innate immune response. Notably, the protein level of FBXO22 were negatively correlated with SARS-CoV-2 load, highlighting its importance in inhibiting viral replication. This study elucidates the molecular mechanism by which FBXO22 mediates the degradation of NSP5 and underscores its critical role in limiting viral replication. The identification of FBXO22 as a regulator of NSP5 stability provides new insights and potential avenues for targeting NSP5 in antiviral strategies.
Keywords: NSP5; SARS‐CoV‐2; degradation; ubiquitination; viral replication.